Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo’s Victoza, new indication to reduce CV risk
Novo’s Victoza, new indication to reduce CV risk
Novo’s Victoza, new indication to reduce CV risk
Submitted by
admin
on August 27, 2017 - 6:24pm
Source:
GoInPharma
News Tags:
Novo Nordisk
Victoza
diabetes
cardiovascular disease
Headline:
Novo’s Victoza, new indication to reduce CV risk
Do Not Allow Advertisers to Use My Personal information
